Real-world efficacy and predictors of response to modified electroconvulsive therapy in patients with depression aged ≤30 years: a retrospective observational study

Frontiers in Psychiatry | New and Recent Articles ·
Mind & Mental Health Switzerland

BackgroundModified electroconvulsive therapy (MECT) is an effective treatment for severe and treatment-resistant depression; however, real-world evidence on its efficacy and predictors in patients aged ≤30 years remains limited.MethodsWe retrospectively reviewed 39 inpatients aged ≤30 years (median age 17 years; 76.9% female) who received bitemporal MECT under etomidate–succinylcholine anesthesia…

Read original article on Frontiers in Psychiatry | New and Recent Articles →